Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

INNOVANCE Antithrombin AssayState-of-the-art antithrombin testing

 

The INNOVANCE® Antithrombin Assay is a state-of-the-art reagent for the detection of congenital or acquired antithrombin deficiencies. The ready-to-use reagent offers improved onboard stability and, due to its Xa-based activity, shows excellent sensitivity to detect antithrombin mutations.

Features & Benefits


Stable reagents
  • Good method correlation offers harmonized result interpretation and helps avoid the need for repeat testing, saving time and reagents.
  • Available in different ready-to-use kit sizes, reducing waste and providing cost and labor efficiencies.

Fast turnaround time
  • Ready-to-use liquid reagent provides excellent precision and uses standard calibrators and controls for simplified system adaption.
  • Available for any sized lab on the BCS® XP System, Sysmex® CA-600 and CS Systems, and Atellica® COAG 360 System1

Validated diagnostic
  • The ready-to-use reagent offers improved onboard stability and, due to its Xa-based activity, shows excellent sensitivity to detect antithrombin mutations.2

Technical Specifications

10 µL
Required sample volume, depending on system application

0–140% of norm
Measuring range on BCS XP System

48 hours
Onboard stability on BCS® XP System

3.7%
Within-device/lab CV (%) of Control Plasma N on BCS XP System

100/430 tests per kit3
Number of tests per kit for small/large kit configuration

4 weeks
Stability after reconstitution at 2–8°C

Clinical Use


GTH COVID-19 treatment recommendations

GTH COVID-19 treatment recommendations

Hospitalized patients with SARS-CoV-2 infection should be continually monitored. Reasonable laboratory parameters include D-dimer, prothrombin time (Quick/INR), platelet count, fibrinogen, and antithrombin.4,5

1
2
3
4
5